BIRC5 and ovarian cancer: Not only did survivin knockdown by itself reduce the viability of ovarian cancer cells in support of the earlier results obtained by using YM155 (Figure 4a), the combination of survivin knockdown and cisplatin treatment also reduced cell viability more effectively than either alone (Figure 8b).